FDA proposes mandatory e-safety reporting rules
Rules strengthen data collection
The U.S. Food and Drug Administration (FDA) has proposed to amend postmarket safety reporting regulations to require that manufacturers and other facilities subject to current reporting requirements submit reports in an electronic format, according to an FDA news bulletin.
The proposed rules apply to electronic medical device adverse event (AE) reporting and electronic drug and biologic product adverse experience reporting. The rules only change the way incidents are reported, but do not change what sites are required to report.
Most mandatory medical device AE reporting to the FDA's Center for Devices and Radiological Health (CDRH) have been in paper format, which requires manual entry into the center's AE database, which is called the Manufacturer and User Facility Device Experience (MAUDE) database. The extra step of data entry hinders CDRH's ability to review safety data quickly to uncover potential public health problems, and it's costly, FDA officials say.
The U.S. Food and Drug Administration (FDA) has proposed to amend postmarket safety reporting regulations to require that manufacturers and other facilities subject to current reporting requirements submit reports in an electronic format, according to an FDA news bulletin.You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content